NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,360,887 | +14609.5% | 903,272 | +19354.5% | 0.01% | – |
| Q2 2023 | $118,025 | -58.9% | 4,643 | -41.6% | 0.00% | – |
| Q1 2023 | $287,501 | +495.6% | 7,953 | +552.4% | 0.00% | – |
| Q4 2022 | $48,273 | +154.1% | 1,219 | +206.3% | 0.00% | – |
| Q3 2022 | $19,000 | -86.9% | 398 | -87.9% | 0.00% | – |
| Q2 2022 | $145,000 | -36.7% | 3,289 | +3.7% | 0.00% | – |
| Q1 2022 | $229,000 | +301.8% | 3,172 | +351.2% | 0.00% | – |
| Q4 2021 | $57,000 | -26.0% | 703 | +6.2% | 0.00% | – |
| Q3 2021 | $77,000 | -29.4% | 662 | +0.6% | 0.00% | – |
| Q2 2021 | $109,000 | -84.1% | 658 | -86.6% | 0.00% | – |
| Q1 2021 | $685,000 | +4.6% | 4,914 | +29.9% | 0.00% | – |
| Q4 2020 | $655,000 | +104.0% | 3,784 | +64.2% | 0.00% | – |
| Q3 2020 | $321,000 | +426.2% | 2,304 | +348.2% | 0.00% | – |
| Q2 2020 | $61,000 | -20.8% | 514 | -33.6% | 0.00% | – |
| Q1 2020 | $77,000 | -86.0% | 774 | -83.5% | 0.00% | – |
| Q4 2019 | $551,000 | -1.3% | 4,688 | -27.8% | 0.00% | – |
| Q3 2019 | $558,000 | +33.8% | 6,489 | +0.9% | 0.00% | – |
| Q2 2019 | $417,000 | -36.9% | 6,433 | -39.2% | 0.00% | – |
| Q1 2019 | $661,000 | +303.0% | 10,573 | +149.8% | 0.00% | – |
| Q4 2018 | $164,000 | -42.0% | 4,232 | -14.7% | 0.00% | – |
| Q3 2018 | $283,000 | -33.7% | 4,961 | -7.2% | 0.00% | – |
| Q2 2018 | $427,000 | -9.9% | 5,345 | -2.4% | 0.00% | – |
| Q1 2018 | $474,000 | +73.0% | 5,479 | +38.0% | 0.00% | – |
| Q4 2017 | $274,000 | -48.7% | 3,970 | -32.5% | 0.00% | – |
| Q3 2017 | $534,000 | -81.7% | 5,881 | -85.0% | 0.00% | -100.0% |
| Q2 2017 | $2,922,000 | +42.7% | 39,254 | +79.7% | 0.00% | +100.0% |
| Q1 2017 | $2,047,000 | -23.8% | 21,845 | -40.9% | 0.00% | 0.0% |
| Q4 2016 | $2,685,000 | +1197.1% | 36,956 | +1768.4% | 0.00% | – |
| Q3 2016 | $207,000 | +28.6% | 1,978 | -8.9% | 0.00% | – |
| Q2 2016 | $161,000 | +57.8% | 2,171 | +20.1% | 0.00% | – |
| Q1 2016 | $102,000 | -95.2% | 1,808 | -94.2% | 0.00% | -100.0% |
| Q4 2015 | $2,112,000 | +2793.2% | 31,290 | +1884.1% | 0.00% | – |
| Q3 2015 | $73,000 | +10.6% | 1,577 | +27.5% | 0.00% | – |
| Q2 2015 | $66,000 | +34.7% | 1,237 | +20.4% | 0.00% | – |
| Q1 2015 | $49,000 | -31.0% | 1,027 | -43.8% | 0.00% | – |
| Q4 2014 | $71,000 | – | 1,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |